Provided by Tiger Fintech (Singapore) Pte. Ltd.

Enanta Pharmaceuticals

6.23
-0.0700-1.11%
Volume:19.04K
Turnover:121.16K
Market Cap:132.90M
PE:-1.26
High:6.46
Open:6.34
Low:6.17
Close:6.30
Loading ...

Enanta Pharmaceuticals Inc. : Oppenheimer Cuts Target Price to $14 From $16

THOMSON REUTERS
·
27 Nov 2024

Enanta Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $10 From $12

THOMSON REUTERS
·
27 Nov 2024

Enanta Pharmaceuticals Shares Fall 5% After Q4 Results

THOMSON REUTERS
·
26 Nov 2024

Enanta Pharmaceuticals Price Target Cut to $21.00/Share From $22.00 by JMP Securities

Dow Jones
·
26 Nov 2024

Enanta price target lowered to $20 from $26 at Baird

TIPRANKS
·
26 Nov 2024

U.S. RESEARCH ROUNDUP-Allstate, Mongodb, Primerica

Reuters
·
26 Nov 2024

Enanta Pharmaceuticals: Promising RSV Developments and Strong Immunology Pipeline Justify Buy Rating

TIPRANKS
·
26 Nov 2024

Enanta Pharmaceuticals Reports Q4 2024 Financials

TIPRANKS
·
26 Nov 2024

Enanta Pharmaceuticals Inc : Baird Cuts Target Price to $20 From $26

THOMSON REUTERS
·
26 Nov 2024

Enanta Pharmaceuticals Fiscal Q4 Net Loss Widens, Revenue Declines

MT Newswires Live
·
26 Nov 2024

Enanta Pharmaceuticals (ENTA) Reports Q4 Loss, Misses Revenue Estimates

Zacks
·
26 Nov 2024

Enanta Pharmaceuticals Inc reports results for the quarter ended September 30 - Earnings Summary

Reuters
·
26 Nov 2024

Enanta Pharmaceuticals: Fiscal Q4 Earnings Snapshot

Associated Press Finance
·
26 Nov 2024

Enanta Pharma Q4 EPS $(1.36) Down From $(1.33) YoY, Sales $14.61M Down From $18.93M YoY

Benzinga
·
26 Nov 2024

Enanta Pharmaceuticals Sees Q4 2024 Revenue $14.6M Vs $17.9M Estimate; Sees Adj. EPS $-1.36 Vs $-1.16

Benzinga
·
26 Nov 2024

Enanta reports Q4 EPS ($1.36), consensus (92c)

TIPRANKS
·
26 Nov 2024